Blend of, GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg

KLOW Peptide Blend 80mg

The KLOW Peptide 80mg blend is a specialist multi-peptide research formulation combining four separate compounds within one lyophilised vial. The formulation contains GHK-Cu, BPC-157, TB-500 and KPV, giving researchers the ability to study a combined peptide preparation rather than sourcing each compound separately. Each KLOW vial supplied by N&A Peptides contains a total of 80mg of peptide material, consisting of 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV. KLOW is intended exclusively for laboratory, analytical and scientific research purposes.

What is KLOW 80mg?

KLOW is the name commonly used for a four-component peptide blend containing GHK-Cu, BPC-157, TB-500 and KPV. Rather than representing a single peptide molecule, KLOW combines several separately studied peptide compounds into one research formulation. This makes the product particularly relevant to researchers investigating peptide interactions, peptide stability, analytical testing and multi-compound research models. The total content of this formulation is 80mg per vial.

KLOW 80mg composition

Each vial contains: GHK-Cu – 50mg GHK-Cu is a naturally occurring copper-binding peptide that has been the subject of laboratory research across a range of biochemical and cellular research areas. BPC-157 – 10mg BPC-157 is a synthetic peptide frequently examined in preclinical and laboratory research environments. TB-500 – 10mg TB-500 is a synthetic peptide fragment associated with thymosin beta-4 research and is commonly used in experimental peptide studies. KPV – 10mg KPV is a short tripeptide consisting of the amino acids lysine, proline and valine and has been investigated within laboratory research settings. Together, these compounds form the KLOW peptide blend 80mg. KLOW Peptide 80mg is supplied as a lyophilised research blend containing four peptide components in one vial.

Lyophilised research preparation

KLOW 80mg is supplied in lyophilised form. Lyophilisation is a freeze-drying process frequently used when preparing peptides for laboratory storage and research. The product is supplied as a sealed research vial to help protect the material during storage and transportation. Researchers should always follow appropriate laboratory procedures when handling peptide compounds. The composition of KLOW Peptide 80mg includes GHK-Cu, BPC-157, TB-500 and KPV. Researchers working with multi-peptide formulations may use KLOW Peptide 80mg for controlled laboratory analysis.

Research applications

KLOW is intended for controlled scientific and analytical research. Research involving the individual peptides within KLOW has included areas such as peptide chemistry, molecular interaction studies, cellular research, analytical testing and peptide stability. Research findings concerning individual ingredients should not automatically be assumed to apply to the combined KLOW formulation. The four-component formulation should therefore be treated as a separate research preparation.

Storage

Keep the product securely sealed and protected from excessive heat, direct sunlight and moisture. Follow the storage information printed on the supplied product packaging and associated laboratory documentation.

Important research notice

KLOW Peptide 80mg is supplied strictly for laboratory and research purposes. It is not supplied for human consumption, self-administration, diagnosis, treatment or prevention of disease. The buyer is responsible for ensuring that the product is handled appropriately and used in accordance with applicable laboratory procedures and regulations.

---

Product specifications